Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

EPAA Annual conference November Regulatory acceptance of alternative approaches for pharmaceuticals Jean-Marc Vidal Safety & Efficacy of Human Medicines.
Good Clinical Practice in Research Clinical Trial Regulations
Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
ROLE OF THE PHYSICIAN IN THE APPROVAL PROCESS Stephanie de Bono MD PhD Medical Advisor, Eli Lilly.
Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Special populations- What makes them so special? AGAH Association for Applied Human Pharmacology Annual meeting 2004 Berlin 29. Februar 2004 Birka Lehmann.
Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.
ICM/WHO Global Standards for Midwifery Regulation Dr Sally Pairman Co-chair ICM/WHO Global Taskforce on Midwifery Regulation Washington DC 2010.
Implementation - Medical Devices. Overview Act on Medical Devices – background and overview. Surveillance - Competent authority. Directive 93/42. Directive.
ICH GCP, the MHRA and PATHOLOGY PATHOLOGY QUALITY ASSURANCE Rob Wosley MRQA SEPTEMBER 2009.
Responsible Sponsorship A case study Dr Birgit Whitman, Head of Research Governance.
Introduction to Regulation
John Naim, PhD Director Clinical Trials Research Unit
CUMC IRB Investigator Meeting Special IND/IDE Considerations: Emergency Use of Investigational Product Compassionate Use & Emergency Research July 21,
An introduction to the EU and its legislation. Member States currently 15 –Austria- Ireland –Belgium- Luxembourg –Denmark- Netherlands –Finland- Portugal.
You need to consider whether a Patient Group Direction (PGD) would be appropriate for an area of practice that involves the supply or administration of.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
1 The Increasingly Important Role of US and EU Cooperation in GCP in Europe and Globally Steps toward Harmonization DHHS Secretary’s Advisory Committee.
Pharma.be The Initiative to Promote Clinical Trials in Belgium Key Performance Indicators: Impact on Clinical Research of European Legislation Square –
Summary About me & AMRC About the EU Clinical Trials Regulation – what’s new Implementation timeline What does this mean for UK ethicists?
Research Ethics Review Malaysian experince Dato Dr. Zaki Morad. Chairperson MREC Dr. Lim TO. Member MREC MOH Malaysia.
Ethics and Regulatory Approvals Alison Robertson CMDHB Research Officer.
1 The Impact of the EU Proposed Research Regulation on the Legal, Ethical, and Social Aspects of Clinical Trials Clinical Research Conference 2012 Clinical.
Federal Food, Drug, and Cosmetic Act 1938, 1954, 1958 (FFDCA) Katie Buhai Period 3.
Registrant Engagement Through CPD Aoife Sweeney, Head of Education, CORU - Health and Social Care Professionals Council, Ireland.
Local Public Health System Assessment using the NPHPSP Local Instrument Essential Service 6 Enforce Laws and Regulations that Protect Health and Ensure.
Regulatory Primer 101 Patrick Kennelly, Chief Food Safety Section California Department of Public Health March 11, 2014.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
The OSH Act, Standards, & Liabilities
ClinicalTrials.gov Tutorial Chicago Urban Health Outreach Project ClinicalTrials.gov Tutorial Use the buttons below to navigate. Start by clicking the.
PATRICIA KERBY, MPA HUMAN SUBJECTIONS PROTECTION COMPLIANCE OFFICER OFFICE OF RESEARCH COMPLIANCE What are the FDA’s expectations in 2010?
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
Igniting our potential Research Governance Issues in Higher Education Brunswick Sub Group: 2 March 2006 Standardised Agreements.
Saftey Agencies in Healthcare Practice OSHA CDCP CLIA FDA ISO WHO NIH USDHHS.
ClinicalTrials.gov Results Reporting, Unique Evidence, and the Role of Medical Librarians SCR CONNECTions March 19, 2014.
Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.
Anne Mette Dons, MD Head of Department Supervision and Patient Safety
$100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 Terms Clinical Trial Facts.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
National Public Health Performance Standards Local Assessment Instrument Essential Service:6 Enforce Laws and Regulations that Protect Health and Ensure.
Understanding Clinical Trials – Part 2 Georgianne Arnold, MD Professor of Pediatrics University of Pittsburgh Medical Center Pittsburgh Children’s Hospital.
October 28, F OOD AND DRUG ADMINISTRATION AMENDMENTS ACT OF 2007 (FDAAA) and Risk Evaluation and Mitigation Strategies (REMS) Presented to the Ninth.
SEVESO II transposition and implementation: Possible approaches and lessons learned from member states and new member states SEVESO II transposition and.
Indian Clinical Trials- The Unaddressed Challenges of Regulatory Amendments Dr. N. Srinivas Principal Malla Reddy Institute of Pharmaceutical Sciences.
The Changing Face of EU Legislation Is the EU moving towards the FDA model of pharmaceutical legislation? By Robert Smith Director.
Overcoming challenges in pediatric oncology product development: Regulatory oversight of multi-national clinical studies Ursula Kern, Advisory Committees.
New from 2013… to 2017 Declaration of Helsinki 2013 Updated definition of Critical Audit Finding from HRA April 2014 European Regulation 2014 Care Act.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 1 – Free movement of goods Bilateral.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
Chapter 22 REGULATORY AND ADVISORY AGENCIES. Introduction 2.
Briefing on MHRA routine inspection of non-commercial clinical trials
CLINICAL TRIALS.
ROLES AND RESPONSIBILITIES OF TFDA ON ADDO PROGRAM
Regulatory Updates Health Sciences Authority Singapore
Update on EU regulatory developments
ClinicalTrials.gov Requirements
Nordic Cooperation on Ethical Review Procedures Nordforsk – nordic trial alliance MIKA SCHEININ
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
EudraVigilance.
Administering Informed Consent Issues for Discussion
REGULATORY PROBLEMS IN CARING OUT PRE- AND POST- AUTHORISATION CLINICAL TRIALS Dr Penka Decheva GCP Inspector, BDA.
UK Legal Requirement for Notification of Serious Breaches of Good Clinical Practice or The Trial Protocol John Poland, PhD Senior Director, Regulatory.
Bozeman Health Clinical Research
Cindy Murray NP Princess Margaret Cancer Centre
Research, Experimentation, & Clinical Trials
Stakeholder Engagement: Webinar Part I: The Regulatory Development Process for the Government of Canada Part II: Making Technical Regulations Under.
Presentation transcript:

Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner

What is or should be the role of government in clinical trials?

The Role of Government Regulatory framework Patient safety Stimulate and encourage activity Training schemes Part of an effective healthcare system Delivery of political goals and objectives Delivery of progressive healthcare Ensure they don’t lose votes

How do Governments Discharge this Duty? Well the U.S informs it’s citizens about clinical trials like this

How do Governments Discharge this Duty? In the U.S ClinicalTrials.gov offers up-to-date information for locating federally and privately supported clinical trials for a wide range of diseases and conditions. A clinical trial (also clinical research) is a research study in human volunteers to answer specific health questions. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.

How do Governments Discharge this Duty? ClinicalTrials.gov currently contains 78,364 trials sponsored by the National Institutes of Health, other federal agencies, and private industry. Studies listed in the database are conducted in all 50 States and in 172 countries ClinicalTrials.gov receives over 40 million page views per month 50,000 visitors daily. The U.S. National Institutes of Health (NIH), through its National Library of Medicine (NLM), has developed this site in collaboration with the Food and Drug Administration (FDA), as a result of the FDA Modernization Act, which was passed into law in November See the FDA document - Guidance for Industry: Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions (March 2002).Food and Drug Administration (FDA)Guidance for Industry: Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions

Clinical Trials.gov Provides information Extensive FAQs for potential participants Information on how to become an investigator Details on what trials are taking place e.g. “ClinicalTrials.gov currently has 78,861 trials with locations in 171 countries”.

Clinical Trials.gov Clinical trials are registered with ClinicalTrials.gov via a web based data entry system called the Protocol Registration System (PRS).ClinicalTrials.gov ClinicalTrials.gov allows the reporting of trials that: Are in conformance with any applicable human subject or ethics review regulations (or equivalent) and Are in conformance with any applicable regulations of the national (or regional) health authority (or equivalent)

Regulation of Trials Example: The EU Clinical Trials Directive (EUCTD)

EU Clinical Trials Directive (EUCTD) Directive 2001/20/EC of the European Parliament and of the Council……. “on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use”

EU Directive  Came into force 01 May 2001  Member States had to publish legislation by May 2003 and enact the law(s) by May 2004  Law in most Member States but still not all.  Enacted in the UK by The Medicines for Human Use (Clinical trials) Regulations 2004 (SI No. 031)

EU Directive - Effect on UK clinical research  Applies to ALL clinical trials on humans involving medicinal products (investigational medicinal products (IMPs) except” non-interventional trials”  Includes non-commercial studies  Includes Phase 1 studies

“GCP Directive” – 2005/28/EC 08/04/2005 -“laying down principles and detailed guidance for good clinical practice as regards investigational medicinal products for human use, as well as requirements for authorisation of the manufacturing or importation of such products.”

Government Enforces the Rules How does it do this? In the UK we have the MHRA (Medicines and Healthcare Products regulatory Agency)

The Medicines and Healthcare products Regulatory Agency (MHRA) is the government agency which is responsible for ensuring that medicines and medical devices work, and are acceptably safe. No product is risk-free. Underpinning all our work lie robust and fact-based judgements to ensure that the benefits to patients and the public justify the risks.

“We keep watch over medicines and devices, and we take any necessary action to protect the public promptly if there is a problem”. “We aim to make as much information as possible publicly available”. “We enable greater access to products, and the timely introduction of innovative treatments and technologies that benefit patients and the public”.

“We encourage everyone - the public and healthcare professionals as well as industry - to tell us about any problems with a medicine or medical device, so that we can investigate and take any necessary action”

The GCP Inspectorate? Ensuring the Rules are met for Clinical Trials In the UK, the GCP inspectorate is responsible for inspecting clinical trials for compliance with Good Clinical Practice. Statutory Instrument 2004/1031 and subsequent amendment 2006/1928 provides the legal basis for these inspections.

In India? Here you have Schedule Y of the Drugs and Cosmetics Act You can learn about this yourself or may be familiar with it form other lectures

Government and Regulation Conclusion In this presentation you have had an insight into government as a stakeholder in the clinical trials process You should now have some understanding of what it does You will learn more over the coming year.